Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers from the University of Oxford teamed up with the Angolan Ministry of Health to study the introduction and circulation of the Asian genotype of Zika virus in Angola, southwestern Africa. The Asian genotype caused the 2015-16 epidemic of microcephaly and other birth defects in the Americas.

Their findings are published today in The Lancet Infectious Diseases.

In 2017 Angola started reporting cases of microcephaly in newborns. Until that point only the African genotype of Zika was known to circulate in Africa.

Researchers from Oxford’s Department of Zoology and the Instituto Nacional de Investigação em Saúde in Luanda, followed up on reports of microcephaly cases in Angola, which they suspected could be caused by Zika virus infection in pregnancy. They carried out molecular testing and genome sequencing to understand the virus’s genetic history and its epidemiology in this ground-breaking genomic detective work. This is the first time that complete virus genomes have been generated on-site in Angola.

Read more (University of Oxford website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.